Home / Gemcitabine / Germany
DE ATC L01BC05 · updated 2 Nov 2026
Gemcitabine shortage in Germany
Is there a Gemcitabine shortage in Germany?
Yes. As of 2 Nov 2026, 3 Gemcitabine products are reported short in Germany, the first since 4 Dec 2023. The company estimate for the return is 31 Jan 2027. Main reason: manufacturing problem.
Also short in Canada, France, Italy, Spain, Belgium, Switzerland, Czechia, Australia. All countries.
Affected products in Germany
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Bendacitabin 38 mg/ml | BENDALIS GmbH | 4 Dec 2023 | 31 Jan 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Bendacitabin 38 mg/ml | BENDALIS GmbH | 4 Dec 2023 | 31 Jan 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Bendacitabin 38 mg/ml | BENDALIS GmbH | 4 Dec 2023 | 31 Jan 2027 | Manufacturing problem Probleme in der Herstellung |
Source
BfArM (Federal Institute for Drugs and Medical Devices), via PharmNet.Bund. Official list. Supply-relevant medicines reported under a voluntary self-commitment; mostly hospital-relevant products.